R.G Clemence - Concepedia

Author

R.G Clemence

Pfizer (United Kingdom)

Also Known As

Karine Savary-Bataille, R. CLEMENCE, R. G. CLEMENCE, R. G. Clemence, R.G Clemence

Publications

632

Citations

H-Index

Concepts

All Affiliations

Pfizer (United Kingdom)Pfizer (United States)

About

R.G Clemence is an author at Pfizer (United Kingdom) specializing in medicine, veterinary science, and parasitology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	375
2	Allergy	3	3	131
3	Anesthesia	1	1	45
4	Biochemistry	1	1	80
5	Gastroenterology	1	1	18

R.G Clemence

Publications

622

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of selamectin against Sarcoptes scabiei on dogs and Otodectes cynotis on dogs and cats presented as veterinary patients Robert H. Six, R.G Clemence, C.A Thomas, Veterinary Parasitology AllergyVeterinary PathologyVeterinary ScienceVeterinary ResearchSmall Animal Internal Medicine	2000	96
Comparative efficacy of maropitant and selected drugs in preventing emesis induced by centrally or peripherally acting emetogens in dogs H. S. SEDLACEK, Deborah S. Ramsey, Joseph F. Boucher, Journal of Veterinary Pharmacology and Therapeutics	2008	83
Selamectin is a potent substrate and inhibitor of human and canine P‐glycoprotein Joanna Griffin, Nicola F. Fletcher, R.G Clemence, Journal of Veterinary Pharmacology and Therapeutics Molecular PharmacologyNeuropeptidesBiochemistryPotent SubstrateMedicine	2005	80
The pharmacokinetics of maropitant, a novel neurokinin type‐1 receptor antagonist, in dogs H. A. Benchaoui, Steven R. Cox, Richard Schneider, Journal of Veterinary Pharmacology and Therapeutics NeuropeptidesOral BioavailabilityPharmacological StudyAbsolute BioavailabilityMedicine	2007	75
The anti‐emetic efficacy of maropitant (Cerenia™) in the treatment of ongoing emesis caused by a wide range of underlying clinical aetiologies in canine patients in Europe Victor A. de la Puente-Redondo, E. M. Siedek, H. A. Benchaoui, Journal of Small Animal Practice	2007	70
Safety and efficacy of injectable and oral maropitant, a selective neurokinin<sub>1</sub> receptor antagonist, in a randomized clinical trial for treatment of vomiting in dogs Deborah S. Ramsey, K. Kincaid, J. A. Watkins, Journal of Veterinary Pharmacology and Therapeutics	2008	48
Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs H. A. Benchaoui, E. M. Siedek, Victor A. de la Puente-Redondo, Veterinary Record	2007	46
Efficacy and safety of maropitant, a selective neurokinin<sub>1</sub> receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs George A. Conder, H. S. SEDLACEK, Joseph F. Boucher, Journal of Veterinary Pharmacology and Therapeutics Animal PhysiologyVeterinary Behavioral MedicinePharmacologyVeterinary ScienceReceptor Antagonist	2008	45
Efficacy of selamectin against experimentally induced and naturally acquired ascarid (Toxocara canis and Toxascaris leonina) infections in dogs Tom L. McTier, E. M. Siedek, R.G Clemence, Veterinary Parasitology MedicineVeterinary PathologyVeterinary SciencePathologySmall Animal Internal Medicine	2000	26
Efficacy and safety of selamectin against fleas on dogs and cats presented as veterinary patients in Europe H. A. Benchaoui, R.G Clemence, P.J.M Clements, Veterinary Parasitology AllergyAntiparasitic AgentVeterinary PathologyPharmacologyVeterinary Science	2000	19

Page 1